And although immunoassays are difficult to develop quickly, researchers in Singapore were able to create one for SARS-CoV-2 even before COVID-19 was declared a pandemic.
A pesar de que es difícil desarrollar inmunoanálisis con rapidez, los investigadores de Singapur pudieron elaborar uno para el SARS-CoV-2 incluso antes de que se declarara la pandemia del COVID-19.